| INTRODUCTION
Myelin Regulatory Factor (MYRF) has been previously shown to play a vital role in the normal maintenance of myelin by oligodendrocytes, but has not been implicated in any Mendelian disease (Duncan et al., 2017) .
The protein is highly expressed outside of the nervous system, and its expression is higher in the stomach than the brain (Fagerberg et al., 2014) . Although it is a transcription factor, little is known about its role outside the nervous system (Duncan et al., 2017) . We report here two (Table 1) .
| RESULTS

| Individual 1
Individual 1 was a male born at 41 weeks gestation to a 27-year-old G2P1 mother; his mother had previously experienced a spontaneous abortion at 14 weeks gestation. There were no reported exposures. At were noted on ultrasound. He was delivered by Cesarean section for prolonged rupture of membranes and had a birth weight of 3,875 g (75%), length of 54.5 cm (95%), and head circumference of 34 cm 
| Individual 2
Individual 2 was a male born at 37.5 weeks gestation to a 30-year-old G2P1 who had previously experienced a spontaneous abortion at 6 weeks gestation. There were no reported exposures during the pregnancy. A complex congenital heart defect with pericardial effusion was identified at 20 weeks gestation by ultrasound. He was born by spontaneous vaginal delivery with a birth weight of 2,650 g (6th%), length of 46 cm (2nd%), and head circumference of 33.5 cm (22nd%). On a postnatal echocardiogram it was determined that his complex congenital heart disease was comprised of near interruption of the aortic arch with transverse arch hypoplasia with a mildly hypoplastic bicuspid valve, a large ventricular septal defect, large PDA, dextroposition with hypoplasia of the right pulmonary artery, and likely an interrupted inferior vena cava. In addition the right ventricle was mildly dilated and hypertrophied. It was also determined that he had a right congenital diaphragmatic hernia (CDH), with extension of the hepatic dome into the right hemithorax.
He had tachycardia up to 315 beats per minutes, which was treated with adenosine. On exam shortly after birth he was found to have a 3 | DISCUSSION
| MYRF
MYRF has been shown to be essential for myelination during development and plays an important role in the remyelination of multiple sclerosis lesions (Duncan et al., 2017) . It has never been associated previously with a Mendelian disorder. Nevertheless, it is highly expressed in developing diaphragm in mouse (with mean expression values of 9.04, 8.74, and 8.01 at embryonic Day (E)11.5, E12.5, and E16.5, respectively), and demonstrates constraint in the context of both missense (z = 2.39) and loss of function (pLI = 1.00) variants per the Exome Aggregation Consortium (ExAC) (Russell et al., 2012) . The two variants here are both predicted to cause loss of function in the protein, one is a stop gain before the last exon that likely triggers nonsense mediated decay. The other is a variant that ablates a canonical splice site and would lead to aberrant splicing. MYRF is a membrane-associated transcription factor that is activated through autocatalytic cleavage via the peptidase S74 domain to bind the enhancer region of target genes (Bujalka et al., 2013) . It functions as a homotrimer in vivo in the nucleus to perform its role in transcription (Kim et al., 2017) . Autoprocessing is apparently constitutive and is essential for transcriptional activity. A mouse model lacking MYRF in oligodendrocytes demonstrates severe neurologic dysfunction with seizure and premature death, but no phenotype in heterozygotes is described (Emery et al., 2009 ). It has also been shown to be essential for synaptic plasticity in C. elegans model systems (Meng et al., 2017) .
MYRF is known to be a target of SOX10, which causes some forms of Waardenburg syndrome (MIM 609136, 611584, and 613266) (Hornig et al., 2013 (FPKM = 2.14-17.14), compared to developing brain (FPKM = 0.09-1.61), which supports a role beyond the central nervous system (Mouse et al., 2012) .
| CONCLUSIONS
In 
